SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TOSHI

TOSHI is currently trending as its dedicated community remains highly engaged, actively accumulating the asset and expressing strong conviction despite broader market volatility. Chatter is focused on its role as the "Face of Base" and anticipation of future catalysts like potential Tier 1 exchange listings and the upcoming Toshi Mobile launch, reinforcing its long-term utility beyond a meme coin.

USDC is a fully collateralized US dollar stablecoin. USDC is the bridge between dollars and trading on cryptocurrency exchanges. The technology behind CENTRE makes it possible to exchange value between people, businesses and financial institutions just like email between mail services and texts between SMS providers. We believe by removing artificial economic borders, we can create a more inclusive global economy.

USD Coin

USDC is currently a major talking point as stablecoin regulatory clarity, particularly with the GENIUS Act advancing, boosts confidence in its compliant and transparent nature. The community is actively discussing its expanding utility, with integrations across major financial services like Visa and JPMorgan, solidifying its role in compliant on-chain settlements and collateral in derivatives markets. This growing adoption positions USDC as a foundational asset bridging traditional finance with the evolving digital economy.

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Exact Sciences Corp.

Exact Sciences is trending following its acquisition by Abbott Laboratories for $105 per share, a deal valued at approximately $21 billion. The community is actively discussing this major development in the cancer diagnostics sector, with many celebrating substantial long-term gains while evaluating their next investment moves given the significant buyout offer.

SoftBank Group Corp. operates as a holding company which engages in the management of its group companies. It operates through the following segments: SoftBank Vision Fund, SoftBank, Arm, Brightstar, and Others. The SoftBank Vision Fund segment engages in the investment business. The SoftBank segment provides mobile communication, broadband, and telecom services in Japan. The Arm segment designs microprocessors and develops software technologies. The Brightstar segment engages in the distribution of mobile devices overseas. The Others segment includes the smartphone payments business, alternative investment business, fund business in Latin America and the operation of baseball teams. The company was founded by Masayoshi Son on September 3, 1981 and is headquartered in Tokyo, Japan.

SoftBank Group Corp. - ADR

SoftBank Corp.

SoftBank is actively trending due to its aggressive pursuit of artificial intelligence dominance, highlighted by significant planned investments in U.S. data center facilities for OpenAI's Stargate project and Masayoshi Son's reported push for a substantial AI chip development venture. Community discussion centers on SoftBank's strategic asset divestments, including an Nvidia stake, to fund these expansive AI initiatives and leverage its Arm Holdings ownership. This reflects SoftBank's accelerated drive to lead in next-generation AI infrastructure and computing.

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Quoin Pharmaceuticals Ltd - ADR

Quoin Pharmaceuticals is trending after announcing the successful achievement of target rapamycin loadings for two proprietary topical delivery technologies, advancing its rare disease pipeline. This news, coupled with its extremely low float and recent significant private placement funding, is driving intense community speculation about a potential short squeeze. Traders are actively debating its volatile price action and the possibility of substantial upside, comparing its potential to other low-float runners.

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Protagonist Therapeutics Inc

Protagonist Therapeutics is trending due to significant market chatter surrounding a potential acquisition by Johnson & Johnson, complementing its strong clinical pipeline. The community is highly engaged in discussions about J&J's strategic interest in PTGX's promising immunology and hematology assets, particularly the "practice-changing" rusfertide data and the efficacy of its oral IL-23 receptor antagonist, JNJ-2113.

Colliers International Group, Inc. engages in the provision of commercial real estate services to corporate and institutional clients. It offers outsourcing and advisory services, lease brokerage, and sales brokerage. It operates through the following segments: Real Estate Services, Engineering, Investment Management, and Corporate. The Real Estate Services segment relates to Americas, EMEA, and Asia Pacific regions. The Engineering segment refers to engineering and project management. The Investment Management segment is involved in a global alternative asset manager with long-standing, cycle tested expertise. The Corporate segment includes the costs of global administrative functions and corporate head office. The company was founded on July 31, 1988, and is headquartered in Toronto, Canada.

Colliers International Group Inc

Colliers International (CIGI) is trending due to its strategic partnership with Google Cloud, aimed at accelerating digital and AI-powered innovation within the commercial real estate sector. The community sees this as a pivotal move into AI infrastructure, positioning Colliers for market leadership in this evolving space. Ongoing analyst interest is also evident, reflecting the company's broader strategy of diversifying services through targeted acquisitions.

Codatta

XNY CRYPTO, Codatta, is generating significant community excitement due to its recent strong price action and notable resilience amidst broader market fluctuations. Investors are actively discussing its underlying utility as a decentralized data marketplace for AI and scientific research, where data contributors earn royalties, leading to speculation that this once-overlooked asset is building momentum for further gains.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF ($JEPQ) is trending due to recent dividend announcements, with the community enthusiastically discussing a notable $0.62 per share payout for June as an immediate catalyst. Investors widely embrace JEPQ as a 

ProShares Trust - ProShares Nasdaq-100 High Income ETF

ProShares Nasdaq-100 High Income ETF

ProShares Nasdaq-100 High Income ETF (IQQQ) is actively discussed as a high-yield option, gaining attention amid broader market conversations around tech sector anxieties and the potential for a more dovish monetary policy. The community is noting its strong dividend potential and consistent ETF inflows, positioning it as a long-term income play within the tech-heavy Nasdaq-100 space. Investors are watching its steady higher low structure, considering it an attractive alternative for QQQ-style exposure with an income focus.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul><li>Sui’s price rose 1.3% in the last hour but fell 0.6% over 24 hours.</li><li>The firm also filed for a U.S. spot SUI ETF in May, currently under SEC review.</li><li>Sui currently has a market capitalization of over $6 billion.</li></ul>21Shares on Thursday launched the first leveraged SUI ETF (TXXS) on Nasdaq after receiving approval from the Securities and Exchange Commission (SEC).The ‘21Shares 2x SUI ETF’ offers leveraged exposure to Sui. It aims to deliver 200% of the token’s daily performance through derivatives. Like other leveraged products, it is structured for traders seeking amplified returns linked to Sui’s price movements.At the time of writing,&nbsp;<a href="https://stocktwits.com/coins/sui">Sui’s price</a> had gained 1.3% over the last hour, though it was still down 0.6% over the past day. On Stocktwits, retail sentiment around the altcoin trended in ‘bullish’ territory, accompanied by ‘high’ levels of chatter.&nbsp;<h2 class="st-heading-2">21 Shares Plans SUI Spot ETF Debut</h2>The leveraged fund launch follows 21Shares’ May filing for a spot SUI ETF, which is still under review by the SEC. The proposed spot ETF would provide direct exposure to the SUI token, held in custody by Coinbase, and is aimed at institutional investors seeking access to the Sui ecosystem.The filing also announced a “strategic partnership” with the Sui Layer 1 blockchain, promising product collaborations, research reports, and other initiatives. Canary Capital has also filed for a spot SUI ETF in the U.S. market.Sui is a Layer 1 blockchain developed by Mysten Labs, founded by former Meta Libra employees, using the Move programming language. SUI currently has a market capitalization of over $6 billion, according to CoinGecko.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/tom-lee-predicts-eth-will-outperform-btc-crypto-prices-have-likely-bottomed/cLILMFWRESg">Tom Lee Predicts Ethereum Will Outperform Bitcoin, Says Crypto Prices Have ‘Likely Bottomed’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Repsentative image of a cryptcurrency. (Photo by OsakaWayne Studios/Getty Images)

21Shares Launches First Leveraged SUI ETF On Nasdaq After SEC Approval

The 21Shares 2x Long SUI ETF aims to deliver 200% of SUI’s daily performance using derivatives.

Current Price	$16.59
Prev Close	$17.52
Open	$16.52
Dividend Yield	N/A
50-Day Moving Average	$20.01
Beta	N/A
Avg. Volume	0.00
PE Ratio	N/A

52-Week High	$25.91
52-Week Low	$15.33
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

TXXS
21Shares 2x Long Sui ETF

Feed

News

Sentiment

Fundamentals

Info

Latest TXXS News

TXXS21Shares 2x Long Sui ETF